Boston Scientific Corporation has a P/E ratio of 0 against that of Abbott Laboratories’s 62.32 while Medtronic Inc is showing 33.19 for the same.
SCS portfolio features full-body MRI conditional devices that combine therapy options for personalized pain relief, Next-generation Valve Designed to Reduce Paravalvular Leaking, Improve Procedural Efficiency and Treat More Patients with Expanded Indication over Prior Version, Agreement expands company's access to pulsed field ablation technology, New stroke risk reduction technology designed to advance procedural performance and safety, treat wider range of patients with non-valvular atrial fibrillation, Cardiac Resynchronization Therapy (CRT) Devices, Medical Device ID Cards - Pacemaker, ICD, & CRT devices, Remote Patient Monitoring and Diagnostic Monitoring - Boston Scientific, Boston Scientific Announces Transcatheter Cardiovascular Therapeutics 2020 Investor Update and Conference Call Discussing Third Quarter 2020 Results, Boston Scientific Launches WaveWriter Alpha™ Spinal Cord Stimulator Systems In Europe, Boston Scientific Launches ACURATE neo2™ Aortic Valve System in Europe. Global Payments Inc. (GPN) is set for another landmark as it hit the volume of 1.23 million, Facebook Inc. (FB) last month performance of -0.22% certainly makes it a sizzling prospect.
More Headlines » SEC Filings. Uranium Energy Corp. (UEC) shares are taking a pay cut of -20.93% from the high point of 52 weeks and flying high of 191.43% from the low figure of 52 weeks. See what's happening in the market right now with MarketBeat's real-time news feed. BSX has attracted considerable attention from traders and investors, a scenario that has seen its volume jump 72.37% compared to the previous one. Type: All. 0 equity research analysts rated the shares with a selling strategy, 0 gave a hold approach, 4 gave a purchase tip, 0 gave the firm a overweight advice and 0 put the stock under the underweight category.
During the day, the... As on October 14, 2020, Healthcare Trust of America Inc. (NYSE: HTA) started slowly as it slid -1.53% to $25.70. Stock’s current price level is 6.67% above from estimated low price target while it is 24.04% below the estimated high; and even if the BSX’s share succeeded to reach the median price of $47, then the outlook of +16.6% could come to the excitement of the investors. © Copyright 2020 Morningstar, Inc. All rights reserved. Boston Scientific Corporation (BSX) Sitting On The Launchpad, Waiting For The Long... Sirius XM Holdings Inc. (SIRI) Stock Behavior Isn’t As Predictable As You Think, A Look At The Behavior Of Dada Nexus Limited (DADA) Stock, Fresh Data-Based Insight On Ocean Power Technologies, Inc. (OPTT), Six Flags Entertainment Corporation (SIX) Sitting On The Launchpad, Waiting For The Long Term Buyers, American Axle & Manufacturing Holdings, Inc. (AXL) Volatility Hits 3.96% – Here’s What A Good Investor Should Do, Nano Dimension Ltd. (NNDM) Outlook: Revisiting The Past For Future Insights, Analysts Offer Important Insight on TransAtlantic Petroleum Ltd. (TAT), Analysts provide insight on how high Camber Energy, Inc. (CEI) can go, General Electric Company (GE) Volatility Reaches 3.43% : Sit Tight, MAG Silver Corp.’s (MAG) Plans For Silver-Rich Deer Trail Project. This shows up a 0.9% of Short Interest in company’s outstanding shares on the day. The company posted a value of -$0.09 as earning-per-share over the last full year, while a chance, will post $1.67 for the coming year. For the Profitability, stocks gross margin was +64.08, operating margin was +15.95 and Pretax Margin of +6.40. Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $2.52 Billion. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time. Having a second look at Boston Scientific Corporation (NYSE:BSX) provides that stock’s average daily trading volume for 3 months was 7.31 Million, while it dropped to 7.02 Million when we calculate an average volume for past 10 days. Relative Strength Index, or RSI(14), which is a technical analysis gauge, also used to measure momentum on a scale of zero to 100 for overbought and oversold.
This site is protected by reCAPTCHA and the Google Analysts are in estimates of $0.25 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving down to $1.01 for 2020 with estimates of that growing to $1.67 in next year. Jul 15, 2020 9:52 PM EDT. This next-generation transcatheter aortic valve... Boston Scientific Corporation (NYSE: BSX) today announced it has signed an investment agreement with an exclusive option to acquire Farapulse, Inc., a privately-held company developing a pulsed... Boston Scientific Corporation (NYSE: BSX) announced it has received CE Mark and initiated a limited market release of the fourth generation Vercise Genus™ Deep Brain Stimulation (DBS) System in... Boston Scientific (NYSE: BSX) announced that the U.S. Centers for Medicare and Medicaid Services (CMS) granted a New Technology Add-on Payment (NTAP) for the Eluvia™ Drug-Eluting Vascular Stent... Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming virtual investor conferences. During the day, the stock rose to $41.92 and sunk to $40.695 before settling in for the price of $41.97 at the close. According to WSJ, Uranium Energy Corp. (UEC) obtained an estimated Buy proposal from the 4 brokerage firms currently keeping a deep eye on the stock performance as compares to its rivals. The average estimate is representing an increase of -6.9% in sales growth from that of posted by the company in the same quarter of last year. This particular insider is now the holder of 221,048 in total. Receive a free world-class investing education from MarketBeat. This represents a decline of (23.9) percent on a reported basis, (23.1) percent on an... Boston Scientific Corporation (NYSE: BSX) announced it has received U.S. Food and Drug Administration (FDA) approval for the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device. Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2020 on Wednesday, July 29,... Show 5 10 25 50 100 per page Save my name, email, and website in this browser for the next time I comment. Return on equity ratio or ROE is a significant indicator for prospective investors as they would like to see just how effectively a business is using their cash to produce net earnings. During the day,... Retail Properties of America Inc. (NYSE: RPAI) open the trading on October 14, 2020, with a bit cautious approach as it glided -1.23% to... You have entered an incorrect email address! Learn more.